Wayne Remell Walker Ayro, Inc. (AYRO) insider trading activity

Wayne Remell Walker is Director of AYRO, Inc.. Currently has a direct ownership of 18,405 shares of AYRO, which is worth approximately $13,067. The most recent transaction as insider was on Dec 02, 2024, when has been sold 3,520 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.4K

89.51% 3M change

89.51% 12M change

Total Value Held $13,067

WAYNE REMELL WALKER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Sale (or disposition) back to the issuer	-	3,520 Reduced 16.05%	18,405 Common Stock
Dec 02 2024	BUY Grant, award, or other acquisition	-	83,388 Added 45.03%	101,793 Common Stock
Aug 01 2023	SELL Open market or private sale	$5,964 $0.82 p/Share	7,274 Reduced 3.98%	175,399 Common Stock
May 03 2023	SELL Open market or private sale	$3,336 $0.49 p/Share	6,810 Reduced 3.59%	182,673 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	112,667 Added 37.29%	189,483 Common Stock
Jan 30 2023	SELL Open market or private sale	$2,906 $0.71 p/Share	4,094 Reduced 5.06%	76,816 Common Stock
Nov 01 2022	SELL Open market or private sale	$2,415 $0.59 p/Share	4,094 Reduced 4.82%	80,910 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	65,504 Added 43.52%	85,004 Common Stock
Jan 05 2022	SELL Open market or private sale	$2,649 $1.63 p/Share	1,625 Reduced 7.69%	19,500 Common Stock
Oct 05 2021	SELL Open market or private sale	$5,200 $3.2 p/Share	1,625 Reduced 7.14%	21,125 Common Stock
Aug 04 2021	SELL Open market or private sale	$13,975 $4.3 p/Share	3,250 Reduced 12.5%	22,750 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	26,000 Added 50.0%	26,000 Common Stock

Also insider at

POWW

AMMO, INC. Industrials

Director

WRAP

WRAP TECHNOLOGIES, INC. Technology

PMCB

PharmaCyte Biotech, Inc. Healthcare

Director

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

WRW